Teleflex | TFX - Operating Profit


Teleflex reported $36.34M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Align Technology USD 178.05M 46.66M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.05B 190M Mar/2026
Cooper Companies USD 212.8M 72.4M Dec/2025
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
General Electric Aerospace USD 2.32B 549M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
Haemonetics USD 67.4M 8.9M Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 44.16M 10.04M Mar/2026
Orthofix International USD 6.12M 1.91M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Steris USD 278M 7.1M Dec/2025
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026